Volta Labs, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Volta Labs, Inc. - overview
Established
2018
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2018 by its CEO, Udayan Umapathi, and co-founder Will Langford, Volta Labs, Inc. operates as a biotechnology company that develops solutions to streamline the upstream workflows in genomic sequencing. In March 2022, Volta Labs, Inc. raised USD 20 million in series A funding led by new investor Maverick Ventures, with participation from other new investors Khosla Ventures, Casdin Capital, E14 Funds, Blindspot Ventures, and several individual investors.
Volta Labs, Inc. develops a sequencing technology-agnostic platform that spans from the raw biological sample to sequenceable molecules. The company is reinventing the full-stack hardware, software, chemistry, and biology to create solutions for sample preparation. Its platform integrates components from the electronics, automation, and materials industries with a software stack.
The company will use the series A funding to advance the development of a sequencer-agnostic front-end platform for commercial release in 2023.
Current Investors
Y Combinator, Acequia Capital, Khosla Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.voltalabs.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.